Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis Elson

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Medicinal Chemistry|January 13, 2025
Identification of a Chemical Probe for BLT2 Activation by Scaffold HoppingVictor Hernandez-Olmos, Jan Heering, Niklas Ildefeld, et al.
Journal of Medicinal Chemistry|July 2, 2025
Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective InhibitorSebastian Mandel, Thomas Hanke, Niall Prendiville, et al.
ACS Chemical Biology|February 11, 2025
Workflow for E3 Ligase Ligand Validation for PROTAC DevelopmentNebojša Miletić, Janik Weckesser, Thorsten Mosler, et al.
Archiv Der Pharmazie|January 10, 2026
New Quinoline Kinase Inhibitors With Good Selectivity for NAK Kinases and Anti-Tumor Activity Against Ewing SarcomaCaroline de Bem Gentz, Thais Helena Maciel Fernandes, Marcela Silva Lopes, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Medicinal Chemistry|January 13, 2025
Identification of a Chemical Probe for BLT2 Activation by Scaffold HoppingVictor Hernandez-Olmos, Jan Heering, Niklas Ildefeld, et al.
Journal of Medicinal Chemistry|July 2, 2025
Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective InhibitorSebastian Mandel, Thomas Hanke, Niall Prendiville, et al.
ACS Chemical Biology|February 11, 2025
Workflow for E3 Ligase Ligand Validation for PROTAC DevelopmentNebojša Miletić, Janik Weckesser, Thorsten Mosler, et al.
Archiv Der Pharmazie|January 10, 2026
New Quinoline Kinase Inhibitors With Good Selectivity for NAK Kinases and Anti-Tumor Activity Against Ewing SarcomaCaroline de Bem Gentz, Thais Helena Maciel Fernandes, Marcela Silva Lopes, et al.
Pageof 3